265. Hodgkin's Disease; T Cell Disorders Flashcards
What are the 4 markers of normal mature T Cells?
CD 2, 3, 5, 7 (CD3 most important)
Peripheral T Cell/NK Cell Lymphoma (GENERAL)
- epi
- tumor behavior
More common in ASIA
Usually AGGRESSIVE
Adult T Cell Leukemia/Lymphoma (ATLL)
- etiology
- epi, demo
- CP
- prognosis
- morph (blood smear)
- cell of origin
- marker
E: HTLV-1 (Human T-cell Lymphoma Virus)
Epi: Japan, Caribbean, Central Africa
Demo: Adults only (avg 58yo) - exposed to virus early in life
CP: VaRiEs - leukemic, lymphomatous, smoldering
Prognosis: AGGRESSIVE, POOR (<10% survive 5 years)
Morph: lymphocytes with FLOWER-SHAPED NUCLEI
Cell of origin: CD4+ T Cell
Marker: loss of CD7
Anaplastic Large Cell Lymphoma (ALCL)
- epi (2 subtypes)
- genetics
- prognosis (2 subtypes)
- morph (blood smear)
- marker
Epi: ALK+ ALCL more common in PEDIATRICS; ALK- ALCL more common in ELDERLY
Gene: ALK+ ALCL has t(2;5) or other translocation (ALK on Ch2)
Prognosis: ALK+ is FAVORABLE, ALK- is POOR
Morph: HALLMARK CELLS (large cells, horseshoe nuclei)
IHC: CD30+ (all types), ALK+ (only subtype)
Extranodal NK/T Cell Lymphoma, Nasal Type
- etiology
- site of involvement
- prognosis
- markers
MOST ARE NK
Eti: EBV+
Sites: nasal cavity most common (can occur elsewhere)
Prognosis: POOR
IHC: NK phenotype (surface CD3-, cytoplasmic CD3+, CD56+, cytotoxic molecules+), EBV+
- NK cells therefore are stain CD3+ but flow cytometry CD3-!!!
Mycosis Fungoides and Sezary Syndrome
- epi
- morph (blood smear)
- cell of origin
- marker
- prognosis
- triad of Sezary Syndrome
MF
- epi: most common primary cutaneous T Cell Lymphoma
- morph: CEREBRIFORM nuclei
- cell: CD4+ T cells
- IHC: CD7-
- Prognosis: INDOLENT
Sezary
- Erythroderma
- Generalized Lymphadenopathy
- Peripheral blood with CERIBRIFORM (convoluted) nuclei (Sezary cells - neoplastic)
Hodgkin Lymphoma
- two major WHO categories of HL
- features/prognosis of first category
- features of second category (demo, markers, morph)
- most common subtype of second category (CP)
- Nodular Lymphocyte Predominant HL (5% pts)
- B Cell Neoplasm
- GOOD prognosis - Classical HL (95% pts)
- demo: BIMODAL age (younger and older adults)
- markers: CD3-, CD20- (lose B cell), CD30+, CD15+ (KEY), PAX5+ (retains B cell transcription factor)
- morph: REED-STERNBERG CELLS (large cell, bilobed nuclei, prominent nucleoli)
Nodular Sclerosis Classical HL
- 80% involve mediastinum